Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
BRILLERIET NYT SYN HAMMEL ApS
APS
Active
CVR 30610490
Østergade 13, 8450
Hammel
Retail sale of medical and orthopaedic goods
·
NACE 4774
Est. 2007 · 19 years old
6 employees
Monitor
Share
Denmark
/
Companies
/
Retail sale of medical and orthopaedic goods
/
BRILLERIET NYT SYN HAMMEL ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
6M
5M
3M
2M
0M
2021: 5M
5M
2021
2022: 3M (-40% vs 2021)
3M
-40%
2022
2023: 3M (0% vs 2022)
3M
0%
2023
2024: 3M (0% vs 2023)
3M
0%
2024
2025: 4M (+33% vs 2024)
4M
+33%
2025
EBITDA
DKK millions
2M
2M
1M
1M
0M
2021: 2M
2M
2021
2022: 1M (-50% vs 2021)
1M
-50%
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 1M (0% vs 2023)
1M
0%
2024
2025: 1M (0% vs 2024)
1M
0%
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Revenue
3.839
3.482
3.476
3.324
5.153
Staff expenses
-2.137
-2.159
-2.203
-2.073
-1.743
EBITDA
1.219
824
829
676
1.563
Depreciation & amort.
-140
-147
-139
-127
-176
EBIT
1.080
677
690
550
1.387
Net financials
-111
-61
-13
-13
-13
Profit before tax
969
616
677
536
1.375
Tax
222
145
164
133
310
Net profit
747
472
513
403
1.065
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
3.558
3.134
2.799
2.623
3.209
Equity
2.578
2.256
1.985
1.846
2.343
Long-term debt
0
0
0
0
0
Short-term debt
980
878
814
774
853
Total debt
980
878
814
774
853
Financial ratios
5-year trend
EBITDA margin
31,8 %
This company
15,8 %
Market median
This company
Market median
101% above market
2021
2025
Equity ratio
72,5 %
This company
38,2 %
Market median
This company
Market median
90% above market
2021
2025
Return on equity
29,0 %
This company
18,4 %
Market median
This company
Market median
58% above market
2021
2025
Net profit margin
19,5 %
This company
8,1 %
Market median
This company
Market median
141% above market
2021
2025
Asset turnover
1,08×
This company
1,12×
Market median
This company
Market median
4% below market
2021
2025
Debt / equity
0,38×
This company
0,62×
Market median
This company
Market median
39% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on BRILLERIET NYT SYN HAMMEL ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
